Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**MYOSEAL** is an investigational, locally applied prophylactic wound-healing product developed at the University of California, San Francisco for prevention of incisional hernia following open abdominal surgery. It combines a fibrin tissue sealant with metallic silver microparticles and is intended to be applied to a sutured myofascial incision immediately after abdominal-wall closure. The proposed mechanism is local enhancement of early myofascial wound healing and collagen deposition, strengthening the incision and reducing later hernia formation. A registered Phase 1 study of MYOSEAL for this use was withdrawn. ([surgicalinnovations.ucsf.edu](https://surgicalinnovations.ucsf.edu/myoseal))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on MYOSEAL.